Status:

COMPLETED

Memantine for Spasticity in MS Patients

Lead Sponsor:

University of Rochester

Collaborating Sponsors:

Forest Laboratories

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

Participants (n=20) will be identified at routine care visits performed at the Rochester Multiple Sclerosis Center. Eligible participants will have MS by McDonald Criteria,7 and will have a modified A...

Detailed Description

This is a randomized, placebo controlled, double-blind, parallel group trial of memantine in patients with MS and spasticity. Participants will be identified at routine care visits at the Rochester Mu...

Eligibility Criteria

Inclusion

  • Multiple sclerosis by McDonald Criteria.
  • Spasticity. A minimum score of two on the Ashworth spasticity scale in at least one lower extremity muscle group and a total score of at least four in the lower extremity muscles tested.
  • Age 18-70.
  • Normal renal function (estimated CrCl \> 50 ml/min).
  • Women of childbearing potential (i.e., those not postmenopausal or surgically sterile) may participate provided that they are using adequate birth control methods (including barrier methods, IUD, and oral contraceptives) for the duration of the study.
  • Willing and able to perform all procedures related to the clinical trial and to provide informed consent.

Exclusion

  • Evidence of clinically significant thyroid, gastrointestinal, cardiovascular, hepatic, renal, hematologic, respiratory, neoplastic, endocrine (including diabetes mellitus), neurologic (other than MS), or other medical or psychiatric disorder at screening.
  • Women must not be pregnant or lactating. Serum or urine pregnancy tests will be required prior to randomization for women of childbearing potential unless the last menstrual period started less than 28 days prior to randomization.

Key Trial Info

Start Date :

July 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2009

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT00638027

Start Date

July 1 2006

End Date

February 1 2009

Last Update

December 7 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Rochester

Rochester, New York, United States, 14642